Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 19;8(1):99.
doi: 10.1186/s40792-022-01456-z.

A rare case of synchronous multiple primary malignancies of breast cancer and diffuse large B-cell lymphoma that responded to multidisciplinary treatment: a case report

Affiliations

A rare case of synchronous multiple primary malignancies of breast cancer and diffuse large B-cell lymphoma that responded to multidisciplinary treatment: a case report

Yuichi Ueda et al. Surg Case Rep. .

Abstract

Background: Multiple primary malignancies of breast cancer and diffuse large B-cell lymphoma (DLBCL) are rare. Here, we report a case of advanced breast cancer and DLBCL managed with multidisciplinary therapy preceded by surgery with a successful outcome.

Case presentation: During a medical examination, a 71-year-old woman was diagnosed with a right breast mass, enlarged lymph nodes throughout the body, and a splenic tumor. The results of the clinical examination and imaging were suggestive of widely spread breast cancer with lymph node metastasis and malignant lymphoma with systemic metastasis. The histological evaluation of the biopsied breast tissue revealed human epidermal growth factor receptor 2 (HER2)-positive breast cancer, whereas the histological evaluation of the excised inguinal lymph node revealed DLBCL. 18F-FDG PET/computed tomography was performed, and it was determined that both breast cancer and DLBCL were in an advanced stage. Thus, mastectomy was performed, and the axillary lymph nodes showed mixed metastasis of breast cancer and DLBCL. Soon after, the R-CHOP therapy was initiated (375-mg/m2 rituximab, 2-mg/m2 vincristine, 50-mg/m2 doxorubicin, 750-mg/m2 cyclophosphamide, and 125-mg methylprednisolone). After irradiation of the spleen, trastuzumab was administered for 1 year.

Conclusions: We experienced a case of combined breast cancer and DLBCL, which was difficult to treat because both were in advanced stages. Thorough staging of the malignancy and discussion by a multidisciplinary team are necessary to determine the optimal treatment strategy.

Keywords: Breast cancer; DLBCL; Double cancer; Multiple primary malignancies; Synchronous.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Histopathological examination of the breast tumor. a HE staining revealed invasive ductal carcinoma of the breast, histological grade III (×10 magnification). b ER negative (×10 magnification). c PgR negative (×10 magnification). d HER2 score3 (× 10 magnification)
Fig. 2
Fig. 2
Histopathological examination of the inguinal lymph nodes. HE staining revealed the loss of the native lymph node architecture and diffused proliferation of large lymphocytes against a background of numerous small lymphocytes and histiocytes (a ×4 magnification; b ×20 magnification). Immunostaining for c CD3; d CD20. The large lymphoid cells are selectively positive for CD20, and numerous CD3-positive small T-lymphocytes are observed in background, supporting the diagnosis of diffuse large B-cell lymphoma (×20 magnification)
Fig. 3
Fig. 3
Pre-treatment PET/CT findings. PET demonstrated an accumulation of 18F fluorodeoxyglucose in the right breast, bilateral axillary, right cervical, intra-abdominal lymph nodes, spleen, and bilateral inguinal lymph nodes. The findings of the a whole body, b right breast, and c spleen are shown
Fig. 4
Fig. 4
Macroscopic and microscopic findings of the resected specimen. a Surgical specimen of the right breast. b Pathological examination of a specimen from the breast showed invasive carcinoma (×4 magnification). c Pathological examination of the right axillary lymph node showed metastatic cells from the breast cancer (×10 magnification). d Pathological examination of the left axillary lymph node showed diffuse large B-cell lymphoma (×10 magnification)
Fig. 5
Fig. 5
Treatment progress chart. After the completion of six courses of R-CHOP, PET–CT showed no lymphoma lesions or new lesions

Similar articles

Cited by

References

    1. Frei KA, Bonel HM, Forrer P, Alleman J, Steiner RA. Primary breast lymphoma, contralateral breast cancer, and bilateral Brenner tumors of the ovary. Obstet Gynecol. 2002;100:1079–1082. - PubMed
    1. Broco S, Bonito N, Jacinto P, Sousa G, Gervásio H. Primary non-Hodgkin lymphoma and invasive ductal carcinoma in the same breast: a rare case report. Clin Transl Oncol. 2009;11:186–188. doi: 10.1007/S12094-009-0337-7. - DOI - PubMed
    1. Hołody Ł, Kunikowska J, Braziewicz J. Simultaneous breast cancer and DLBCL lymphoma—role of PET/CT examination with 18F-FDG and 18F-FES. Nucl Med Rev Cent East Eur. 2018;21:113–114. doi: 10.5603/NMR.a2018.0020. - DOI - PubMed
    1. Woo EJ, Baugh AD, Ching K. Synchronous presentation of invasive ductal carcinoma and mantle cell lymphoma: a diagnostic challenge in menopausal patients. J Surg Case Rep. 2016;2016:rjv153. doi: 10.1093/jscr/rjv153. - DOI - PMC - PubMed
    1. Warren S, Gates O. Multiple malignant tumors. A survey of the literature and statistical study. Am J Cancer. 1932;16:1358–1414.